KR860003204A - 디페닐메틸이민 유도체의 제조방법 - Google Patents

디페닐메틸이민 유도체의 제조방법 Download PDF

Info

Publication number
KR860003204A
KR860003204A KR1019850007727A KR850007727A KR860003204A KR 860003204 A KR860003204 A KR 860003204A KR 1019850007727 A KR1019850007727 A KR 1019850007727A KR 850007727 A KR850007727 A KR 850007727A KR 860003204 A KR860003204 A KR 860003204A
Authority
KR
South Korea
Prior art keywords
group
compound
formula
salt
sup
Prior art date
Application number
KR1019850007727A
Other languages
English (en)
Other versions
KR910002372B1 (ko
Inventor
야스시(외 7) 스즈끼
Original Assignee
야마구찌 에이이찌
데이고꾸조우끼 세이야꾸 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야마구찌 에이이찌, 데이고꾸조우끼 세이야꾸 가부시끼가이샤 filed Critical 야마구찌 에이이찌
Publication of KR860003204A publication Critical patent/KR860003204A/ko
Application granted granted Critical
Publication of KR910002372B1 publication Critical patent/KR910002372B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/72—Hydrazones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/32—Oximes
    • C07C251/50—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals
    • C07C251/58—Oximes having oxygen atoms of oxyimino groups bound to carbon atoms of substituted hydrocarbon radicals of hydrocarbon radicals substituted by nitrogen atoms not being part of nitro or nitroso groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

내용 없음

Description

디페닐메틸이민 유도체의 제조방법
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (2)

  1. 하기일반식(Ⅱ)의 화합물과 하기 일반식(Ⅲ)의 화합물 또는 그의 염을 반응시킴을 특징으로 하는 하기일반식(Ⅰ)의 디페닐메틸이민 유도체의 제조방법.
    NH2- R1(Ⅲ)
    [식중, R1은 히드록실기 : 안카노일옥시기; 또는 R2가 수소원자 또는 저급알킬이고, R3가 수소원자, 저급알킬기, 알카노일기, 패닐기, 카르바모일기 또는 티오카르바모일기인기이다.) 필요하다면, R1이 히드록실기 또는 아미노기인 일반식(Ⅰ)의 생성화합물을 알카노일화시키고, 원한하면, R1이인 일반식(Ⅰ)의 생성화합물을 그의 염으로 전환시킬수 있다.
  2. 제1항에 있어서, 일반식(Ⅱ)의 화합물과 일반식(Ⅲ)의 화합물 또는 그의 염을 용매없이 또는 비활성용매중에서 40℃ 내지 반응혼합물의 환류온도로 반응시키는 방법.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019850007727A 1984-10-19 1985-10-19 디페닐메틸이민 유도체의 제조방법 KR910002372B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP59218679A JPS61100555A (ja) 1984-10-19 1984-10-19 ベンゾフエノンオキシム誘導体
JP218,679 1984-10-19
JP218679/84 1984-10-19

Publications (2)

Publication Number Publication Date
KR860003204A true KR860003204A (ko) 1986-05-21
KR910002372B1 KR910002372B1 (ko) 1991-04-20

Family

ID=16723718

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850007727A KR910002372B1 (ko) 1984-10-19 1985-10-19 디페닐메틸이민 유도체의 제조방법

Country Status (10)

Country Link
US (1) US4673692A (ko)
EP (1) EP0185158B1 (ko)
JP (1) JPS61100555A (ko)
KR (1) KR910002372B1 (ko)
AT (1) ATE32216T1 (ko)
AU (1) AU578979B2 (ko)
CA (1) CA1253871A (ko)
DE (1) DE3561512D1 (ko)
ES (1) ES8609219A1 (ko)
NZ (1) NZ213780A (ko)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6284051A (ja) * 1985-10-07 1987-04-17 Teikoku Hormone Mfg Co Ltd ジフエニルメチルイミン誘導体
EP0496434B1 (en) * 1987-10-22 1999-02-03 The Procter & Gamble Company Photoprotection compositions comprising chelating agents
WO1990011619A1 (en) * 1989-03-23 1990-10-04 Grumman Aerospace Corporation Single trench mosfet-capacitor cell for analog signal processing
US5288896A (en) * 1992-01-15 1994-02-22 Warner-Lambert Company 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor
WO1994005276A1 (en) * 1992-09-08 1994-03-17 Morgan Lee R Cytotoxic compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925472A (en) * 1968-03-01 1975-12-09 Gen Mills Chem Inc Phenolic oximes
US4124725A (en) * 1977-05-16 1978-11-07 Riker Laboratories, Inc. Anti-inflammatory method
US4472435A (en) * 1980-07-31 1984-09-18 Hoffman-La Roche Inc. Benzophenone derivatives useful in treating heart failure
FR2540107B1 (fr) * 1983-01-28 1986-10-17 Inst Rech Chim Biolog Nouveaux derives d'halogenobenzophenone-oxime, utilisation en therapeutique et procede de preparation

Also Published As

Publication number Publication date
EP0185158A1 (en) 1986-06-25
US4673692A (en) 1987-06-16
ES548004A0 (es) 1986-09-01
AU578979B2 (en) 1988-11-10
KR910002372B1 (ko) 1991-04-20
ATE32216T1 (de) 1988-02-15
JPH0477742B2 (ko) 1992-12-09
AU4847185A (en) 1986-04-24
CA1253871A (en) 1989-05-09
EP0185158B1 (en) 1988-01-27
JPS61100555A (ja) 1986-05-19
ES8609219A1 (es) 1986-09-01
DE3561512D1 (de) 1988-03-03
NZ213780A (en) 1989-08-29

Similar Documents

Publication Publication Date Title
KR860001793A (ko) 벤즈 이미다졸 유도체의 제조방법
KR830007686A (ko) 세팔로 스포린 유도체의 제조방법
MY109628A (en) An improved proces for the preparation of substituted indoline derivatives
KR860003204A (ko) 디페닐메틸이민 유도체의 제조방법
KR850002459A (ko) 디히드록시벤즈아미드 유도체 및 그 제조방법
KR850006171A (ko) 피롤리디논 유도체의 제조방법
KR850001724A (ko) 4-페닐-4-옥소-부텐-2-오인산유도체의 제조방법
GB1528440A (en) Process for the preparation of cyclic ketones
KR850005830A (ko) 2-알콕시아미노설포닐벤젠-설포닐우레아의 제조방법
KR830004322A (ko) 항알러지 및 항궤양제 1-옥소-1H-티아졸로 [3,2-a]피리미딘-2-카복사미드와 그의 중간물질
KR890012988A (ko) 3,3-디아릴아크릴 산 아미드의 제법
KR840002821A (ko) N-(2,3-에폭시프로필렌)-n-아르알킬술폰아미드 유도체의 제조방법
KR860004024A (ko) 인돌 제조방법
KR850001165A (ko) 중추 신경계 활성을 갖는 피롤리디논의 제조방법
KR860000268A (ko) N-벤조일-n'-피리미디닐옥시페닐 우레아 화합물류의 제조방법
KR840005114A (ko) 아제티딘 술폰산의 제조방법
KR850005413A (ko) 아미노니트로피리딘의 제조방법
KR850001742A (ko) 큐말산 에스테르의 제조방법
KR860002473A (ko) 4-메틸-5-티오포름아미디노메틸이미다졸 디하이드로클로라이드의 제조방법
GB1360119A (en) 1-benzoyloxy-2-lower alkylaminobenzocycloalkane derivatives
KR840002848A (ko) 유기인산염의 제조방법
KR840002347A (ko) N-(2,6-디클로로페닐)아세트아미딘의 제조방법
KR840004105A (ko) N,n- 치환된 아졸 카복스 아미드 유도체의 제조방법
KR860004066A (ko) 피페라실린(Piperacilline)의 제조방법
KR920007967A (ko) 케탈의 연속 제조방법

Legal Events

Date Code Title Description
A201 Request for examination
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19950322

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee